1
Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia
Condition(s):Immune ThrombocytopeniaLast Updated:January 5, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Immune ThrombocytopeniaLast Updated:January 5, 2024Recruiting
Condition(s):Immune ThrombocytopeniaLast Updated:December 26, 2023Recruiting
Condition(s):Immune ThrombocytopeniaLast Updated:December 20, 2023Recruiting
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:March 1, 2024Recruiting
Condition(s):HAM/TSPLast Updated:February 20, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.